1674-5809
2009 Issue 6
Treatment of polycystic ovary syndrome
CHEN Zi-jiang;HA Ling-xia
CHEN Zi-jiang;HA Ling-xia
..............page:410-412
Anti-diabetic effects of cinnamaldehyde and its molecular mechanisms
ZHANG Wei;XU Yan-cheng;GUO Fang-jian;LI Ming-yi;MENG Ye;XIA Qianya
ZHANG Wei;XU Yan-cheng;GUO Fang-jian;LI Ming-yi;MENG Ye;XIA Qianya
..............page:444-449
Correlation between sex hormone binding globulin and total testosterone and insulin resistance in polycystic ovary syndrome
LI Yang;LIN Jin-fang
LI Yang;LIN Jin-fang
..............page:422-426
Characteristics and prevalence of abnormal glucose metabolism in patients with polycystic ovary syndrome
NI Ren-min;ZHONG Jun-min;CHEN Xiao-li;LI Lin;LI Yu;CHEN Ya-xiao;LIU Wen;YANG Dong-zi
NI Ren-min;ZHONG Jun-min;CHEN Xiao-li;LI Lin;LI Yu;CHEN Ya-xiao;LIU Wen;YANG Dong-zi
..............page:417-421
Effects of cryptotanshinone on ovaries insulin resistance
LIU Yi-chao;LI Wei;WANG Xiu-xiu;CONG Jing;HOU Li-hui;WU Xiao-ke
LIU Yi-chao;LI Wei;WANG Xiu-xiu;CONG Jing;HOU Li-hui;WU Xiao-ke
..............page:427-432
..............page:401-403
..............page:前插页
Gestational diabetes research in China
GUO Xiao-hui;WU Hong-hua
GUO Xiao-hui;WU Hong-hua
..............page:413-416
Ovary insulin resistance in patients with polycystic ovary syndrome
WANG Jing;ZHANG Yue-hui;WU Xiao-ke
WANG Jing;ZHANG Yue-hui;WU Xiao-ke
..............page:454-457
zhong hua yi xue hui tang niao bing xue fen hui qing nian wei yuan hui shou jie qing nian yi shi lun tan hui yi ji yao
hong tian pei ; bao yu zuo
hong tian pei ; bao yu zuo
..............page:470-471
..............page:472-474
Polycystic ovary syndrome and non-alcoholic fatty liver disease
WU Jia-yu;FAN Jian-gao
WU Jia-yu;FAN Jian-gao
..............page:407-409
..............page:449,457,461,480
Vibration perception threshold of type 2 diabetic patients and its influencing factors
SHEN Juan;LIU Fang;ZENG Hui;ZHAO Jun-gong;ZHAO Jun;DONG Yang;JIA Wei-ping
SHEN Juan;LIU Fang;ZENG Hui;ZHAO Jun-gong;ZHAO Jun;DONG Yang;JIA Wei-ping
..............page:440-443
Common variants of MODY genes and polygenic forms of diabetes
WANG Cong-rong;JIA Wei-ping
WANG Cong-rong;JIA Wei-ping
..............page:458-461
tang niao bing he bing zhang zuo mo luan suo zheng yi li
wang zhi da ; dan chun yan ; zheng miao yan ; jiang chun yan ; sun wen qiang ; nie chun yan ; chang bao cheng ; chen li ming
wang zhi da ; dan chun yan ; zheng miao yan ; jiang chun yan ; sun wen qiang ; nie chun yan ; chang bao cheng ; chen li ming
..............page:469
Meta-analysis of aspirin in primary prevention of cardiovascular events in patients with diabetes
WANG Qian;HAN Ping
WANG Qian;HAN Ping
..............page:433-439
Polycystic ovary syndrome and metabolic syndrome
LIANG Xiao-yan
LIANG Xiao-yan
..............page:404-406
..............page:409,416,432,439,471
yi gao xue tang su yang duo zuo -1 lei si wu zhi liao 2 xing tang niao bing de you shi yu yi yi
zou da jin
zou da jin
..............page:466-468
Brown adipose tissue: a new target for the prevention of obesity
SONG Lu-lu;XIAO Jian-zhong;YANG Wen-ying
SONG Lu-lu;XIAO Jian-zhong;YANG Wen-ying
..............page:462-465
Effects of cannabinoid-1 receptor on pancreatic beta-cell function in obese rats
FAN Da-bei;QIN Guijun;YU Qin;JIA He-tang;MA Xiao-jun;YAN Xiao-jie
FAN Da-bei;QIN Guijun;YU Qin;JIA He-tang;MA Xiao-jun;YAN Xiao-jie
..............page:450-453